From March 24, 2024 to March 31, 2024, the company has repurchased 3,275,199 shares, representing 6.96% for $774.65 million. With this, the company has completed the repurchase of 3,275,199 shares, representing 6.96% for $774.65 million under the buyback announced on March 25, 2024.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
274.6 USD | -0.22% | +0.87% | +25.32% |
06-03 | Liquidia's Yutrepia Launch Cleared as Court Denies Injunction | MT |
05-16 | United Therapeutics Insider Sold Shares Worth $545,800, According to a Recent SEC Filing | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+25.32% | 12.21B | |
+49.88% | 56.95B | |
+39.58% | 40.26B | |
-7.63% | 39.32B | |
-5.96% | 28.37B | |
+12.11% | 26.45B | |
-18.83% | 19.41B | |
+30.15% | 12.54B | |
-1.15% | 12.15B | |
-10.05% | 11.05B |
- Stock Market
- Equities
- UTHR Stock
- News United Therapeutics Corporation
- Tranche Update on United Therapeutics Corporation's Equity Buyback Plan announced on March 25, 2024.